Feline leukemia virus lifetime study: whole blood samples increase detection of low positive cats with extended long-term survival
Open Access
- 10 November 2025
- journal article
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 27 (11)
Abstract
Objectives: Thousands of cats in the USA are newly diagnosed with feline leukemia virus (FeLV) each year, and known FeLV-infected cats are increasingly adopted from shelters. This study investigated optimal sample types to identify FeLV-infected cats and predictors of long-term survival in a cohort of FeLV-positive cats followed for up to 8 years after diagnosis. Methods: Previously, 127 FeLV p27 antigen-positive cats were enrolled in a prospective study. Whole blood, plasma and serum were collected at enrollment and monthly for 6 months. All sample types were tested on SNAP FIV/FeLV Combo Test (SNAP) monthly, and results from microtiter plate ELISA (PetChek) for p27 antigen and a quantitative RT-PCR (qPCR) for proviral DNA were used for confirmation and classification of infection status (high positive, low positive or cryptic/negative). After the 6-month testing phase, cats entered a lifetime survival monitoring phase. Owner-reported status in the current study extended previous survival results by 4 years. Results: Testing anticoagulated whole blood on SNAP at enrollment identified five and nine more FeLV-infected low positive cats (n = 29) than plasma or serum, respectively. Although some low positive (n = 11) cats demonstrated variable test results on SNAP with plasma and serum, others (n = 17) were SNAP positive with all three sample types and classified as low positive based on PetChek and qPCR results. After an additional 4 years of monitoring, low positive cats had not reached a median survival, with 19/29 (66%) cats still alive compared with 2/90 (2.2%) high positive cats. Conclusions and relevance: Anticoagulated whole blood on SNAP was a sensitive indicator of FeLV infection relative to plasma and serum and therefore should be the preferred diagnostic sample for FeLV antigen testing. Combining the results of whole blood antigen testing, PetChek and qPCR identified cats as high positive, low positive or cryptic/negative, with high positive cats having higher risk for early mortality. Use of these diagnostic tools facilitates the management of FeLV as a chronic condition.Keywords
Funding Information
- Maddie's Fund
- EveryCat Health Foundation
This publication has 32 references indexed in Scilit:
- Rapid detection of feline leukemia virus provirus integration into feline genomic DNAMolecular and Cellular Probes, 2006
- Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic catsVeterinary Microbiology, 2006
- Re-examination of feline leukemia virus: host relationships using real-time PCRVirology, 2005
- Feline leukaemia provirus load during the course of experimental infection and in naturally infected catsJournal of General Virology, 2001
- Feline leukaemia virus proviral DNA detected by polymerase chain reaction in antigenaemic but non-viraemic (‘discordant’) catsArchives of Virology, 1997
- FIV, FeLV, and FIPV: Interpretation and misinterpretation of serological test resultsSeminars in Veterinary Medicine and Surgery: Small Animal, 1996
- Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virusJournal of the American Veterinary Medical Association, 1991
- The immunobiology of the feline leukemia virusVeterinary Immunology and Immunopathology, 1984
- Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodiesAmerican Journal of Veterinary Research, 1983
- Reactivation of latent feline leukaemia virus infectionNature, 1982